Atara brings an­oth­er ex­pe­ri­enced in­ves­ti­ga­tor on­to its off-the-shelf CAR-T quest in lat­est col­lab­o­ra­tion

An am­bi­tious Atara has signed up an­oth­er can­cer re­search cen­ter to beef up its pipeline of off-the-shelf CAR-T ther­a­pies.

In the new col­lab­o­ra­tion, the Am­gen spin­off $ATRA will “con­tribute re­sources and rel­e­vant ex­pe­ri­ence to the re­search ac­tiv­i­ties” at Mof­fitt Can­cer Cen­ter in Tam­pa, FL. They will work close­ly with Mar­co Davi­la, a vet­er­an re­searcher in the field who trained with top CAR-T in­ves­ti­ga­tor Michel Sade­lain at Memo­r­i­al Sloan Ket­ter­ing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.